Literature DB >> 23113461

Antibiotic use in acute upper respiratory tract infections.

Roger Zoorob1, Mohamad A Sidani, Richard D Fremont, Courtney Kihlberg.   

Abstract

Upper respiratory tract infections account for millions of visits to family physicians each year in the United States. Although warranted in some cases, antibiotics are greatly overused. This article outlines the guidelines and indications for appropriate antibiotic use for common upper respiratory infections. Early antibiotic treatment may be indicated in patients with acute otitis media, group A beta-hemolytic streptococcal pharyngitis, epiglottitis, or bronchitis caused by pertussis. Persistent cases of rhinosinusitis may necessitate the use of antibiotics if symptoms persist beyond a period of observation. Antibiotics should not be considered in patients with the common cold or laryngitis. Judicious, evidence-based use of antibiotics will help contain costs and prevent adverse effects and drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23113461

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  26 in total

Review 1.  Homeopathy Use in the United States and Implications for Public Health: A Review.

Authors:  Michelle L Dossett; Gloria Y Yeh
Journal:  Homeopathy       Date:  2017-12-22       Impact factor: 1.444

2.  Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis.

Authors:  Cynthia L Gong; Kenneth M Zangwill; Joel W Hay; Daniella Meeker; Jason N Doctor
Journal:  J Gen Intern Med       Date:  2018-05-08       Impact factor: 5.128

Review 3.  COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?

Authors:  Feras Jirjees; Ali K Saad; Zahraa Al Hano; Taher Hatahet; Hala Al Obaidi; Yahya H Dallal Bashi
Journal:  Infect Dis Rep       Date:  2021-04-01

Review 4.  Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease.

Authors:  William Walkowski; Justin Bassett; Manmeet Bhalla; Blaine A Pfeifer; Elsa N Bou Ghanem
Journal:  Vaccines (Basel)       Date:  2021-06-02

Review 5.  Vitamin D and airway infections: a European perspective.

Authors:  Armin Zittermann; Stefan Pilz; Harald Hoffmann; Winfried März
Journal:  Eur J Med Res       Date:  2016-03-24       Impact factor: 2.175

Review 6.  Race Against Antimicrobial Resistance Requires Coordinated Action - An Overview.

Authors:  J Premanandh; B S Samara; A N Mazen
Journal:  Front Microbiol       Date:  2016-02-02       Impact factor: 5.640

7.  Knowledge, attitudes and practices towards antibiotic use in upper respiratory tract infections among patients seeking primary health care in Singapore.

Authors:  Darius Shaw Teng Pan; Joyce Huixin Huang; Magdalene Hui Min Lee; Yue Yu; Mark I-Cheng Chen; Ee Hui Goh; Lili Jiang; Joash Wen Chen Chong; Yee Sin Leo; Tau Hong Lee; Chia Siong Wong; Victor Weng Keong Loh; Adrian Zhongxian Poh; Tat Yean Tham; Wei Mon Wong; Fong Seng Lim
Journal:  BMC Fam Pract       Date:  2016-11-03       Impact factor: 2.497

8.  A multifaceted approach to decrease inappropriate antibiotic use in a pediatric outpatient clinic.

Authors:  Jaffar A Al-Tawfiq; Amel H Alawami
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

9.  Does additional antimicrobial treatment have a better effect on URTI cough resolution than homeopathic symptomatic therapy alone? A real-life preliminary observational study in a pediatric population.

Authors:  Alessandro Zanasi; Salvatore Cazzato; Massimiliano Mazzolini; Carla Maria Sofia Ierna; Marianna Mastroroberto; Elena Nardi; Antonio Maria Morselli-Labate
Journal:  Multidiscip Respir Med       Date:  2015-08-07

10.  Reducing antibiotic prescriptions for respiratory tract infections in family practice: results of a cluster randomized controlled trial evaluating a multifaceted peer-group-based intervention.

Authors:  Marcia Vervloet; Marianne A Meulepas; Jochen W L Cals; Mariëtta Eimers; Lucas S van der Hoek; Liset van Dijk
Journal:  NPJ Prim Care Respir Med       Date:  2016-02-04       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.